ABOUT DIAMYD MEDICAL
ABOUT DIAMYD MEDICAL
CEO Comments
The Diamyd Story
Board & Management
Contact Us
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
Diamyd US Operations
Partnering
DIABETES
DIABETES
Type 1
LADA
Type 2
Complications
Diamyd
®
Products
PRODUCTS & PIPELINE
PRODUCTS & PIPELINE
Diamyd
®
Products
Diamyd
®
for type 1
Diamyd
®
for LADA
NTDDS products
NP2
NG2
NC3
Partnering
SCIENCE & TECHNOLOGY
SCIENCE & TECHNOLOGY
GAD platform
NTDDS platform
Clinical development
Scientific publications
Scientific advisory board
CLINICAL TRIALS
CLINICAL TRIALS
Phase III Trials - USA
Phase III Trials - Europe
INVESTOR RELATIONS
INVESTOR RELATIONS
Press Releases
Financial Reports
IR Calendar
Owners
Share Trading
Board & Management
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
PRESS ROOM
PRESS ROOM
Press Releases
News & Mediawatch
Webcasts/Podcasts
Newsletter Subscription
Media Contact
Home
»
Investor Relations
»
Share Trading
Share Trading
The Diamyd Medical share is traded on the
NASDAQ OMX Nordic Exchange
. Trading list: SSE Small Cap.
Share information
Tickername
Reuter ric
ISIN-code
Orderbook ID
DIAM B
Diam.st
SE 0000337917
18765
Global Industry Classification Standard
(GISC)
Sub Industry Code
Subindustry
35202010
Pharmaceuticals
Business Index
Index code
Index name
SX35PI
Sx35 Health Care_PI
SX3520PI
SX3520 Pharmaceuticals & Biotechn_PI
SX352020PI
SX352020 Pharmaceuticals_PI
Number of outstanding shares and votes as of July 30, 2010
A-shares
B-Shares
Total shares
Total votes*
1 437 876
27 622 401
29 060 277
4 200 116
* One A-share entitles one (1) vote and one B-share entitles one tenth (0.1) of a vote.
ADR Share Trading (US)
On April 20, 2006, the Company launched a Level One American Depositary Receipt (ADR) Program. This will enable US investors in Diamyd Medical to trade in a dollar-denominated security.
Trading symbol:
CUSIP number:
Ratio:
DMYDY
252788 10 4
1 ADR
=
1 ordinary Diamyd class B share
Diamyd Medical has appointed The Bank of New York as the depositary bank for the ADR Program. For more information please contact the bank on: Phone: +1 212 815 3700 Tel from the US: 1 888 269 2377 (1 888 BNY ADRS) Email: shareowners@bankofny.com
INSTRUCTIONS TO TRADE
:
To Trade Diamyd Shares in the US, please call any of the phone numbers below or email their corresponding email addresses.
Buy side
Bank of New York
Julio Lugo
Managing Director
jlugo@bankofny.com
Telephone 212 815 2122
Buy side
Broker Marketing Group
Jason Smith
Telephone 212-815-3874
Sell side
Bank of New York
Jason L. Paltrowitz
Vice President
jpaltrowitz@bankofny.com
Telephone 212 815 2077
Investor Relations
Press Releases
Financial Reports
IR Calendar
Owners
Share Trading
Board & Management
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
The Diamyd share
Related links
Nasdaq OMX Nordic
The Bank of New York
Pink OTC Markets (otcQX)